Arkolith/Insider Trading/RYZB/Form 4

Redmile Biopharma Investments II, L.P.

10% OwnerRayzeBio, Inc. (RYZB) · full profile →Form 4 · filed Sep 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2023Conversion(C)495K——1.4M
Sep 19, 2023Conversion(C)499K——1.9M
Sep 19, 2023Conversion(C)865K——865K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2023Conversion(C)432K—$00
Sep 19, 2023Conversion(C)499K—$00
Sep 19, 2023Conversion(C)865K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-102920) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML